Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001496626 | SCV001701328 | likely benign | Familial infantile myasthenia | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002563303 | SCV003547210 | uncertain significance | Inborn genetic diseases | 2022-09-22 | criteria provided, single submitter | clinical testing | The c.2212A>G (p.K738E) alteration is located in exon 15 (coding exon 15) of the CHAT gene. This alteration results from a A to G substitution at nucleotide position 2212, causing the lysine (K) at amino acid position 738 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001496626 | SCV003833222 | uncertain significance | Familial infantile myasthenia | 2019-06-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706222 | SCV005220714 | likely benign | not provided | criteria provided, single submitter | not provided |